• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名前列腺癌患者出现乳腺及腋窝转移的意外发现。

The unexpected finding of breast and axillary metastases in a patient with prostate carcinoma.

作者信息

Balbino Marina, Montatore Manuela, Masino Federica, Gifuni Rossella, Muscatella Gianmichele, Sciaqua Alessio, Guglielmi Giuseppe

机构信息

Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Viale L. Pinto 1, 71122 Foggia, Italy.

Radiology Unit, "Dimiccoli" Hospital, Viale Ippocrate 15, 70051, Barletta, Italy.

出版信息

Radiol Case Rep. 2025 Aug 27;20(11):5715-5718. doi: 10.1016/j.radcr.2025.08.012. eCollection 2025 Nov.

DOI:10.1016/j.radcr.2025.08.012
PMID:40917484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12410196/
Abstract

We report a rare case of breast and axillary metastases in a 75-year-old man diagnosed with prostate carcinoma. Initially, the patient presented with lower urinary tract symptoms (LUTS) and elevated prostate-specific antigen (PSA) levels. Prostate cancer was confirmed by biopsy and treated with androgen deprivation therapy (ADT) and radiotherapy. At the time the breast mass was detected, the patient was already undergoing ADT. Two years and 2 months after diagnosis, he developed a palpable mass in the left breast. Imaging and ultrasound-guided biopsy revealed metastatic prostate adenocarcinoma involving the breast and ipsilateral axillary lymph nodes, initially suspected as primary breast cancer or gynecomastia secondary to hormonal therapy. Systemic ADT was reinitiated, and palliative radiotherapy was administered to the breast. The patient responded favorably, with a significant PSA reduction and disease stabilization. This case emphasizes the importance of recognizing atypical metastatic sites in prostate cancer and the critical role of combined imaging and histopathological evaluation. Further research is needed to elucidate the mechanisms and clinical implications of such rare metastatic patterns.

摘要

我们报告了一例75岁男性前列腺癌伴乳腺及腋窝转移的罕见病例。最初,患者出现下尿路症状(LUTS)且前列腺特异性抗原(PSA)水平升高。经活检确诊为前列腺癌,并接受了雄激素剥夺治疗(ADT)和放疗。在检测到乳腺肿块时,患者已在接受ADT治疗。诊断后两年零两个月,他左侧乳房出现可触及肿块。影像学检查和超声引导下活检显示为转移性前列腺腺癌,累及乳腺及同侧腋窝淋巴结,最初怀疑为原发性乳腺癌或激素治疗继发的男性乳房发育症。重新开始全身ADT治疗,并对乳房进行姑息性放疗。患者反应良好,PSA显著降低,病情稳定。该病例强调了认识前列腺癌非典型转移部位的重要性以及联合影像学和组织病理学评估的关键作用。需要进一步研究以阐明这种罕见转移模式的机制及临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f8/12410196/d38ccb5306c2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f8/12410196/b7a5b810ad01/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f8/12410196/43d61c236f07/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f8/12410196/d38ccb5306c2/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f8/12410196/b7a5b810ad01/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f8/12410196/43d61c236f07/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9f8/12410196/d38ccb5306c2/gr3.jpg

相似文献

1
The unexpected finding of breast and axillary metastases in a patient with prostate carcinoma.一名前列腺癌患者出现乳腺及腋窝转移的意外发现。
Radiol Case Rep. 2025 Aug 27;20(11):5715-5718. doi: 10.1016/j.radcr.2025.08.012. eCollection 2025 Nov.
2
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分:晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.
3
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.对于开始接受雄激素剥夺治疗的转移性前列腺癌患者使用二甲双胍:STAMPEDE平台方案的一项随机3期试验
Lancet Oncol. 2025 Jul 7. doi: 10.1016/S1470-2045(25)00231-1.
4
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.正电子发射断层扫描(PET)和磁共振成像(MRI)在早期乳腺癌腋窝淋巴结转移评估中的应用:系统评价和经济评估。
Health Technol Assess. 2011 Jan;15(4):iii-iv, 1-134. doi: 10.3310/hta15040.
5
A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.一项关于恶性脊柱转移瘤的证据的系统回顾:自然病史和识别高风险椎体骨折和脊髓压迫患者的技术。
Health Technol Assess. 2013 Sep;17(42):1-274. doi: 10.3310/hta17420.
6
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.局限性和局部晚期前列腺癌的新辅助和辅助激素治疗
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006019. doi: 10.1002/14651858.CD006019.pub2.
7
Comparative Effectiveness of Management Strategies for Stage IV Prostate Cancer: A Narrative Review.IV期前列腺癌管理策略的比较效果:一项叙述性综述
Cureus. 2025 Aug 5;17(8):e89396. doi: 10.7759/cureus.89396. eCollection 2025 Aug.
8
Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial.恩杂鲁胺与转移性前列腺癌患者的前列腺特异性抗原水平:ARCHES随机临床试验的二次分析
JAMA Netw Open. 2025 May 1;8(5):e258751. doi: 10.1001/jamanetworkopen.2025.8751.
9
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer.联合固定疗程全身治疗与转移灶定向放疗用于寡转移激素敏感性前列腺癌
Eur Urol Oncol. 2025 Jun;8(3):709-715. doi: 10.1016/j.euo.2024.10.014. Epub 2024 Nov 14.
10
Matching-adjusted indirect comparison of enzalutamide versus darolutamide doublet in mHSPC.恩杂鲁胺与达罗他胺双重疗法在转移性去势敏感性前列腺癌中的匹配调整间接比较
Future Oncol. 2025 Aug;21(19):2459-2469. doi: 10.1080/14796694.2025.2526324. Epub 2025 Jul 14.

本文引用的文献

1
Survival in male breast cancer over the past 3 decades.男性乳腺癌患者近 30 年的生存状况。
J Natl Cancer Inst. 2023 Apr 11;115(4):421-428. doi: 10.1093/jnci/djac241.
2
Metastasis pattern and prognosis of male breast cancer patients in US: a population-based study from SEER database.美国男性乳腺癌患者的转移模式与预后:一项基于监测、流行病学和最终结果(SEER)数据库的人群研究
Ther Adv Med Oncol. 2019 Nov 16;11:1758835919889003. doi: 10.1177/1758835919889003. eCollection 2019.
3
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
男性乳腺癌的特征:EORTC 10085/TBCRC/BIG/NABCG 国际男性乳腺癌项目的结果。
Ann Oncol. 2018 Feb 1;29(2):405-417. doi: 10.1093/annonc/mdx651.
4
Benign and Malignant Male Breast Diseases: Radiologic and Pathologic Correlation.男性乳腺良恶性疾病:放射学与病理学对照
Can Assoc Radiol J. 2015 Aug;66(3):198-207. doi: 10.1016/j.carj.2015.01.002. Epub 2015 Jun 12.
5
Paget's disease of the male breast with underlying ductal carcinoma in situ ('DCIS').男性乳腺佩吉特病伴原位导管癌(“DCIS”)。
J Surg Case Rep. 2015 Apr 1;2015(4):rjv037. doi: 10.1093/jscr/rjv037.
6
From the radiologic pathology archives: diseases of the male breast: radiologic-pathologic correlation.从放射病理学档案中:男性乳房疾病:放射病理相关性。
Radiographics. 2013 Mar-Apr;33(2):461-89. doi: 10.1148/rg.332125208.
7
MicroRNA expression profiling of male breast cancer.男性乳腺癌的 microRNA 表达谱分析。
Breast Cancer Res. 2009;11(4):R58. doi: 10.1186/bcr2348. Epub 2009 Aug 10.
8
The rising incidence of male breast cancer.男性乳腺癌发病率的上升。
Breast Cancer Res Treat. 2009 May;115(2):429-30. doi: 10.1007/s10549-008-0053-y. Epub 2008 May 14.
9
Male breast cancer: a multicentric study.男性乳腺癌:一项多中心研究。
Breast J. 2007 Mar-Apr;13(2):213-5. doi: 10.1111/j.1524-4741.2007.00412.x.
10
Male breast cancer: a gender issue.男性乳腺癌:一个性别问题。
Nat Clin Pract Oncol. 2006 Aug;3(8):428-37. doi: 10.1038/ncponc0564.